Clinical Trial Update: Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)

View source ↗

Summary

The ABx-CVVHDF trial examining drug monitoring of anti-infective agents in patients receiving continuous venovenous hemodiafiltration has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Need for Renal Replacement Therapy and Anti-infective Therapy Due to Severe Infection | Status: WITHDRAWN